Jag Capital Management, LLC Dexcom Inc Transaction History

Jag Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	SELL	$86.06 - $137.93 $5.27 Million - $8.45 Million	-61,236 Reduced 77.44%	17,835 $1.66 Million
Q2 2023 Sep 07, 2023	SELL	$112.47 - $130.98 $93,350 - $108,713	-830 Reduced 1.04%	79,071 $10.2 Million
Q2 2023 Aug 11, 2023	SELL	$112.47 - $130.98 $450,892 - $525,098	-4,009 Reduced 4.82%	79,220 $10.2 Million
Q1 2023 Sep 07, 2023	SELL	$104.0 - $122.92 $5,304 - $6,268	-51 Reduced 0.06%	79,901 $9.28 Million
Q1 2023 Sep 01, 2023	SELL	$104.0 - $122.92 $5,096 - $6,023	-49 Reduced 0.06%	80,050 $9.3 Million
Q1 2023 May 10, 2023	SELL	$104.0 - $122.92 $85,280 - $100,794	-820 Reduced 0.98%	83,229 $9.67 Million
Q4 2022 Sep 07, 2023	BUY	$84.98 - $122.67 $62,205 - $89,794	732 Added 0.92%	79,952 $9.05 Million
Q4 2022 Sep 01, 2023	BUY	$84.98 - $122.67 $74,697 - $107,826	879 Added 1.11%	80,099 $9.07 Million
Q4 2022 Feb 08, 2023	BUY	$84.98 - $122.67 $7.14 Million - $10.3 Million	84,049 New	84,049 $9.52 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Jag Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Jag Capital Management, LLC with notifications on news.